NWPF

News ArchivesRead News

Exposure to industrial solvent 'can increase risk of Parkinson's disease six times'

Friday March 22, 2013

Chemical is banned in food and pharmaceutical industries but is still used as a degreasing agent 30% of U.S. drinking water supplies believed to be contaminated Read more: http://www.dailymail.co.uk/health/article-2061257/Exposure-industrial-solvent
Anthony Bond

dailymail.co.uk - Chemical is banned in food and pharmaceutical industries but is still used as a degreasing agent
30% of U.S. drinking water supplies believed to be contaminated

A team of scientists from the U.S, Canada, Germany and Argentina found that individuals who had been exposed in the workplace to trichloroethylene (TCE) were six-times more likely to develop Parkinson's.

Due to concerns about its toxicity, the use of TCE in the food and pharmaceutical industries has been banned across much of the world since the 1970s.

However, the chemical is still used as a degreasing agent.

Dr Samuel Goldman of The Parkinson's Institute in Sunnyvale, California, who co-led the study published in the journal Annals of Neurology, told the BBC: 'Our study confirms that common environmental contaminants may increase the risk of developing Parkinson's, which has considerable public health implications.

'Our findings, as well as prior case reports, suggest a lag time of up to 40 years between TCE exposure and onset of Parkinson's, providing a critical window of opportunity to potentially slow the disease before clinical symptoms appear.'

Parkinson's disease is caused by a loss of nerve cells in part of the brain.

It can results in limb tremors, slowed movement and speech impairment.

Researchers wanted to look at the impact on people of exposure to six different solvents, including TCE.

The new findings was based on analysis of 99 pairs of twins from America, one twin with Parkinson's and the other without.

Scientists looked at the work history of the twins as well as hobbies and interests, so they could calculate their exposure to solvents.

n the past TCE has been used in glue, carpet-cleaners, paints and dry-cleaning solutions.

It is still used as a degreasing agent for metal parts.

It is also estimated that 30 per cent of U.S. drinking water supplies are contaminated with the chemical.

Dr Michelle Gardner, research development manager at Parkinson's UK, told the BBC that more research needed to be carried out to look at the link between solvents like TCE and Parkinson's.

She added: 'This is the first study to show that the solvent TCE may be associated with an increased risk of developing Parkinson's.

'It is important to highlight that many of the previous uses of this solvent have been discontinued for safety reasons over 30 years ago, and that safety and protection in work places where strong chemicals such as this solvent are used has greatly improved in recent years.'

Two other solvents - perchloroethylene (PERC) and carbon tetrachloride (CCl4) - were also found to pose a significant risk of developing the disease if people were exposed to them.

There was no link found with the three other solvents examined in the study - toluene, xylene and n-hexane.

PERC is used as a dry-cleaning agent and degreasing agent.

CCl4's major use in the past was in the manufacture of chlorofluorocarbons for use as refrigerants.

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression